ImpaRATOR™
Download Product Folder

Lyophilized enzyme for digestion of mucin-type O-glycoproteins and peptides, including sialylated O-glycan species

ImpaRATOR is an O-glycan-dependent protease that digests proteins carrying mucin-type O-glycans, including sialylated species, N-terminally of glycosylated Ser and Thr residues.
ImpaRATOR Lyophilized is available as a lyophilized powder in 2000 unit vials for digestion of 2 mg O-glycosylated protein.
Lyophilized enzyme for digestion of 2 mg mucin-type O-glycoproteins and peptides, including sialylated O-glycan species

For information on how to order, visit Place an Order or contact us directly at order@genovis.com.
One unit ImpaRATOR Lyophilized digests ≥ 95% of 30 µg etanercept at least at one site when incubated in TBS (50 mM Tris-HCl, 150 mM NaCl), pH 7.6 at 37°C for 30 minutes. For O-glycopeptide mapping applications, one unit ImpaRATOR Lyophilized digests 1 µg O-glycosylated protein when incubated in TBS, pH 7.6 at 37°C for 2 hours.
ImpaRATOR Lyophilized is supplied lyophilized in TBS (50 mM Tris-HCl, 150 mM NaCl), pH 7.6, with no preservatives added.
ImpaRATOR Lyophilized is shipped at ambient temperature, and should be stored at -20°C upon arrival.
After reconstitution, the ImpaRATOR enzyme is stable for at least 1 month at +4-8°C.
Download Scientific Poster

Combining multiple digestions for O-glycan site mapping with glycan structure analysis for complete characterization of heavily O-glycosylated proteins.
Broad O-glycan substrate acceptance efficiently generating informative O-glycopeptides while retaining glycan structure information.
ImpaRATOR is a metalloprotease and thereby sensitive to chelating agents such as EDTA. Concentrations > 1 mM EDTA results in complete inhibition of the enzyme. In addition, the ImpaRATOR activity is inhibited by reducing agents and detergents.
ImpaRATOR has a broad activity towards different O-glycan structures; however, the enzyme has limited activity towards sites with two adjacent O-glycosylated Ser/Thr residues. For complete information about O-glycan sites in glycoprotein substrates containing several sites with two adjacent O-glycosylated Ser/Thr residues, OpeRATOR may be a better option.
Insufficient digestion during non-denaturing conditions can be caused by O-glycosylation sites within the glycoprotein inaccessible to the enzyme. In such cases, we recommend trying the following workflow: reduction, denaturation, carboxymethylation, buffer-exchange, and then digestion with ImpaRATOR. If detergent is added, make sure to include a detergent removal step prior ImpaRATOR digestion.
All rights reserved. Genovis products may be covered by one or more patents, trademarks and copyrights owned by Genovis AB or licensed from third parties. For more information about commercial rights, please contact the Genovis team at licensing@genovis.com.
Genovis products are intended for research use only. They are not intended to be used for therapeutic or diagnostic purposes in humans or animals. All goods and services are sold subject to Genovis’ General Terms and Conditions of Sale.
© Genovis AB